These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 7815741

  • 1. [The effect of temocapril, an angiotensin-converting enzyme inhibitor with preferential biliary excretion, on experimental diabetic nephropathy].
    Yanagisawa Y.
    Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1095-102. PubMed ID: 7815741
    [Abstract] [Full Text] [Related]

  • 2. [Renal angiotensin converting enzyme (ACE) expression in diabetic rats: the effect of ACE inhibitors].
    Yoshikawa H.
    Nihon Jinzo Gakkai Shi; 1999 Aug; 41(5):486-92. PubMed ID: 10502942
    [Abstract] [Full Text] [Related]

  • 3. Effect of aspirin on experimental diabetic nephropathy.
    Moel DI, Safirstein RL, McEvoy RC, Hsueh W.
    J Lab Clin Med; 1987 Sep; 110(3):300-7. PubMed ID: 3475395
    [Abstract] [Full Text] [Related]

  • 4. Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats. Protective effects of ACE inhibition.
    Sassy-Prigent C, Heudes D, Jouquey S, Auberval D, Belair MF, Michel O, Hamon G, Bariety J, Bruneval P.
    Lab Invest; 1995 Jul; 73(1):64-71. PubMed ID: 7603042
    [Abstract] [Full Text] [Related]

  • 5. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C, Seidl U, Reinecke A, Riester U, Graf K, Schultheiss HP, Hilgenfeldt U, Unger T.
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [Abstract] [Full Text] [Related]

  • 6. [Mechanisms of prevention of progression of diabetic nephropathy by dietary protein restriction].
    Kobayashi M.
    Nihon Jinzo Gakkai Shi; 1993 Jul; 35(7):835-41. PubMed ID: 8411763
    [Abstract] [Full Text] [Related]

  • 7. Possible role of VEGF in the progression of kidney disease in streptozotocin (STZ)-induced diabetic rats: effects of an ACE inhibitor and an angiotensin II receptor antagonist.
    Kakizawa H, Itoh Y, Imamura S, Matsumoto T, Ishiwata Y, Ono Y, Yamamoto K, Kato T, Hayakawa N, Oda N, Goto Y, Goto Y, Nagasaka A, Senda T, Itoh M.
    Horm Metab Res; 2004 Jul; 36(7):458-64. PubMed ID: 15305228
    [Abstract] [Full Text] [Related]

  • 8. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ, Wang Y, Li Q, Tian YJ, Liu MH, Yu YH.
    Chin Med J (Engl); 2006 May 20; 119(10):814-21. PubMed ID: 16732983
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage.
    Perico N, Amuchastegui CS, Malanchini B, Bertani T, Remuzzi G.
    Exp Nephrol; 1994 May 20; 2(4):220-8. PubMed ID: 8069658
    [Abstract] [Full Text] [Related]

  • 10. [ACE inhibitor effects on structure and function of the glomerular basement membrane].
    Hasslacher C, Bostedt-Kiesel A, Kempe HP.
    Klin Wochenschr; 1992 May 20; 69 Suppl 29():39-44. PubMed ID: 1614191
    [Abstract] [Full Text] [Related]

  • 11. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
    Mathew R, Futterweit S, Valderrama E, Tarectecan AA, Bylander JE, Bond JS, Trachtman H.
    Am J Physiol Renal Physiol; 2005 Oct 20; 289(4):F911-21. PubMed ID: 15942051
    [Abstract] [Full Text] [Related]

  • 12. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats.
    Samnegård B, Jacobson SH, Jaremko G, Johansson BL, Ekberg K, Isaksson B, Eriksson L, Wahren J, Sjöquist M.
    Nephrol Dial Transplant; 2005 Mar 20; 20(3):532-8. PubMed ID: 15665028
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
    Volpini RA, da Silva CG, Costa RS, Coimbra TM.
    Diabetes Metab Res Rev; 2003 Mar 20; 19(1):43-51. PubMed ID: 12592643
    [Abstract] [Full Text] [Related]

  • 16. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
    Zheng Y, Shirato I, Maeda A, Kobayashi N, Liao J, Shou I, Fukui M, Tomino Y.
    J Nephrol; 2002 Mar 20; 15(1):36-41. PubMed ID: 11936424
    [Abstract] [Full Text] [Related]

  • 17. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A, Veksler S, Gafter U, Boner G, Wittenberg C, van Dijk DJ.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep 20; 5(3):146-51. PubMed ID: 15526251
    [Abstract] [Full Text] [Related]

  • 18. C-peptide and captopril are equally effective in lowering glomerular hyperfiltration in diabetic rats.
    Samnegård B, Jacobson SH, Johansson BL, Ekberg K, Isaksson B, Wahren J, Sjöquist M.
    Nephrol Dial Transplant; 2004 Jun 20; 19(6):1385-91. PubMed ID: 15004258
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.